Nimotuzumab High-risk, Locally Advanced Squamous Cell Carcinoma of the Cervix

NCT06771596 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Uterine Cervical Neoplasms

Interventions

DRUG: Nimotuzumab Injection

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences